ENDO INTERNATIONAL PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0006 USD | 0.00% |
|
-14.29% | +20.00% |
| 03-22 | Fourth Amended Joint Reorganization Plan Approved for Endo International plc | CI |
| 03-20 | Health Care Down on Rate Bias -- Health Care Roundup | DJ |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,638 | 1,064 | 1,653 | 878.6 | 16.65 | 0.1176 |
| Enterprise Value (EV) 1 | 8,786 | 8,099 | 8,836 | 7,691 | 6,885 | 7,407 |
| P/E ratio | -1.59 x | -2.5 x | 9.11 x | -1.43 x | -0.01 x | -0 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.56 x | 0.36 x | 0.57 x | 0.29 x | 0.01 x | 0 x |
| EV / Revenue | 2.98 x | 2.78 x | 3.04 x | 2.57 x | 2.97 x | 3.68 x |
| EV / EBITDA | 13.8 x | 12.1 x | 11.2 x | 8.72 x | 14.8 x | 16.8 x |
| EV / FCF | 17.8 x | 40 x | 27.5 x | 10.1 x | -205 x | 15.3 x |
| FCF Yield | 5.61% | 2.5% | 3.64% | 9.92% | -0.49% | 6.52% |
| Price to Book | -3.29 x | -1.23 x | -2.55 x | -0.71 x | -0 x | -0 x |
| Nbr of stocks (in thousands) | 224,345 | 226,776 | 230,292 | 233,671 | 235,200 | 235,220 |
| Reference price 2 | 7.300 | 4.690 | 7.180 | 3.760 | 0.0708 | 0.000500 |
| Announcement Date | 28/02/19 | 26/02/20 | 26/02/21 | 01/03/22 | 06/03/23 | 06/03/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2,947 | 2,914 | 2,903 | 2,993 | 2,319 | 2,012 |
| EBITDA 1 | 638.4 | 668.7 | 790.8 | 882 | 464.2 | 441.5 |
| EBIT 1 | 544.2 | 587.6 | 691.5 | 793 | 409.1 | 386.4 |
| Operating Margin | 18.47% | 20.16% | 23.82% | 26.49% | 17.64% | 19.21% |
| Earnings before Tax (EBT) 1 | -938.8 | -344.9 | -26.52 | -546.6 | -2,888 | -2,392 |
| Net income 1 | -1,031 | -422.6 | 183.9 | -613.2 | -2,923 | -2,450 |
| Net margin | -35% | -14.5% | 6.34% | -20.49% | -126.06% | -121.79% |
| EPS 2 | -4.606 | -1.875 | 0.7881 | -2.634 | -12.45 | -10.42 |
| Free Cash Flow 1 | 492.8 | 202.4 | 321.4 | 762.9 | -33.54 | 482.6 |
| FCF margin | 16.72% | 6.95% | 11.07% | 25.49% | -1.45% | 23.99% |
| FCF Conversion (EBITDA) | 77.2% | 30.27% | 40.64% | 86.51% | - | 109.31% |
| FCF Conversion (Net income) | - | - | 174.73% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 28/02/19 | 26/02/20 | 26/02/21 | 01/03/22 | 06/03/23 | 06/03/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|
| Net sales 1 | 772 | 789.4 | 652.3 | 569.1 |
| EBITDA 1 | 386.9 | 386.5 | 310.9 | 160.2 |
| EBIT 1 | 364.6 | 367.1 | 293.6 | 145.3 |
| Operating Margin | 47.22% | 46.5% | 45.01% | 25.53% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income 1 | -77.21 | -562.1 | -71.97 | -1,885 |
| Net margin | -10% | -71.2% | -11.03% | -331.29% |
| EPS | -0.3300 | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 04/11/21 | 28/02/22 | 05/05/22 | 09/08/22 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 7,149 | 7,036 | 7,182 | 6,812 | 6,869 | 7,407 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 11.2 x | 10.52 x | 9.082 x | 7.724 x | 14.8 x | 16.78 x |
| Free Cash Flow 1 | 493 | 202 | 321 | 763 | -33.5 | 483 |
| ROE (net income / shareholders' equity) | 14,352% | 52.8% | -32.7% | 60.2% | 108% | 45.5% |
| ROA (Net income/ Total Assets) | 3.13% | 3.76% | 4.63% | 5.5% | 3.52% | 4.43% |
| Assets 1 | -33,006 | -11,234 | 3,970 | -11,155 | -83,033 | -55,258 |
| Book Value Per Share 2 | -2.220 | -3.820 | -2.810 | -5.320 | -17.70 | -28.00 |
| Cash Flow per Share 2 | 5.120 | 6.410 | 5.270 | 6.450 | 4.330 | 3.310 |
| Capex 1 | 86.9 | 67.7 | 72.9 | 80.7 | 103 | 94.3 |
| Capex / Sales | 2.95% | 2.32% | 2.51% | 2.69% | 4.44% | 4.69% |
| Announcement Date | 28/02/19 | 26/02/20 | 26/02/21 | 01/03/22 | 06/03/23 | 06/03/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +20.00% | 141K | |
| +137.37% | 5.68B | |
| +1.89% | 1.01B | |
| +2.19% | 982M | |
| +41.91% | 872M | |
| +25.27% | 819M | |
| +1.68% | 663M | |
| +0.54% | 610M | |
| -.--% | 600M | |
| +21.31% | 552M |
- Stock Market
- Equities
- ENDPQ Stock
- Financials Endo International plc
